In recent years, the global peptide drug market has experienced sustained rapid growth, demonstrating unique advantages across multiple therapeutic areas. However, existing synthetic systems still face critical technical bottlenecks, including challenges in controlling side reactions and maintaining chiral purity. As a core reagent for constructing amide bonds, its performance directly impacts bond-forming efficiency, product purity, and yield. Consequently, the innovative development of peptide synthesis reagents has garnered significant attention.